LOGIN  |  REGISTER
Compass Therapeutics

Brookdale Senior Living Reports May 2025 Occupancy

June 09, 2025 | Last Trade: US$7.91 0.10 -1.25

NASHVILLE, Tenn., June 9, 2025 /PRNewswire/ -- Brookdale Senior Living Inc. (NYSE: BKD) reported today its consolidated occupancy for May 2025.

May 2025 Observations:

  • May consolidated weighted average occupancy grew 190 basis points year-over-year and 20 basis points sequentially to 80.0%, achieving a critical milestone for the consolidated portfolio.
  • Driven by strong move-in volume and disciplined sales execution, May same community weighted average occupancy was 80.6%, also increasing 20 basis points sequentially compared to April.
  • May same community month end occupancy grew 50 basis points sequentially to 82.1%, achieving the highest month end sequential increase in the last nine months.
  • Second quarter-to-date consolidated weighted average occupancy of 79.9% represents a 60 basis point sequential occupancy increase from the full first quarter; May 2025 month end occupancy growth accelerated to 50 basis points sequentially from April compared to 30 basis points in the prior year period.

About Brookdale Senior Living

Brookdale Senior Living Inc. is the nation's premier operator of senior living communities. With 647 communities across 41 states and the ability to serve approximately 58,000 residents as of March 31, 2025, Brookdale is committed to its mission of enriching the lives of seniors through compassionate care, clinical expertise, and exceptional service. The Company, through its affiliates, operates independent living, assisted living, memory care, and continuing care retirement communities, offering tailored solutions that help empower seniors to live with dignity, connection, and purpose. Leveraging deep expertise in healthcare, hospitality, and real estate, Brookdale creates opportunities for wellness, personal growth, and meaningful relationships in settings that feel like home. Guided by its four cornerstones of passion, courage, partnership, and trust, Brookdale is committed to delivering exceptional value and redefining senior living for a brighter, healthier future. Brookdale's stock trades on the New York Stock Exchange under the ticker symbol BKD. For more information, visit brookdale.com or connect with Brookdale on Facebook or YouTube.

 

Stock Quote

Featured Stock

Immix Biopharma

Immix Biopharma is a clinical-stage biopharmaceutical company pioneering a novel class of CAR-T cell therapies and Tissue-Specific Therapeutics targeting oncology and immuno-dysregulated diseases with >75 patients treated to-date. Our lead cell therapy asset is NXC-201...

CLICK TO LEARN MORE

Featured Stock

C4 Therapeutics

C4 Therapeutics is pioneering a new class of small-molecule drugs that selectively destroy disease-causing proteins via degradation using the innate machinery of the cell. This targeted protein degradation approach offers advantages over traditional drugs, including the potential to treat a wider range of diseases...

CLICK TO LEARN MORE

End of content

No more pages to load

Next page